Clinical Trial

The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS8179 injection in preventing and treating severe cerebral edema after large area cerebral infarction in the cerebral hemisphere
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-10; most recent amendment 2025-08-18.
Status change: Not Yet Recruiting → Recruiting 2025-02-26
Trial Details
NCT Number NCT06732648
Lead Sponsor Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions Severe Cerebral Edema Following Large Hemispheric Infarction
Enrollment 725 participants
Start Date 2025-02-07
Primary Completion 2027-06 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-22